GSK2850163 is primarily investigated for its potential therapeutic applications in the treatment of inflammatory diseases. It acts as a selective inhibitor of a specific enzyme involved in the regulation of immune responses, making it a promising candidate for managing conditions like rheumatoid arthritis and other autoimmune disorders. Its ability to modulate inflammatory pathways suggests it could help reduce chronic inflammation and associated tissue damage. Ongoing research aims to evaluate its efficacy and safety in clinical settings, potentially offering a new treatment option for patients with limited responses to existing therapies.